News | Magnetic Resonance Imaging (MRI) | July 05, 2018

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

While new research suggests ultra-high-field 7T MRI could pose problems for people with amalgam fillings, conventional 1.5T scans were found to be safe

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

July 5, 2018 — Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in teeth, according to a new study appearing online in the journal Radiology. The effect was not seen, however, in the lower strength, more commonly used 1.5-Tesla (T) MRI.

Amalgam fillings, also known as silver fillings, have been a staple of dentistry for many years. Amalgam consists of approximately 50 percent mercury, a known toxin that can cause a host of harmful effects in humans. Despite the presence of mercury, the U.S. Food and Drug Administration (FDA) considers amalgam fillings safe for adults and children older than age six.

“In a completely hardened amalgam, approximately 48 hours after placing on teeth, mercury becomes attached to the chemical structure, and the surface of the filling is covered with an oxide film layer,” said the study’s lead author, Selmi Yilmaz, Ph.D., a dentist and faculty member at Akdeniz University in Antalya, Turkey. “Therefore, any mercury leakage is minimal.”

Previous research has found that exposure to the magnetic fields of MRI could cause mercury to leak from amalgam fillings. This concern has been heightened by the recent arrival of ultra-high-strength 7T scanners in the clinic. The stronger magnetic field of 7T MRI yields more anatomical detail, but its effects on amalgam dental fillings have not been studied.

To learn more, Yilmaz and colleague, Mehmet Zahit Adişen, Ph.D., evaluated mercury released from dental amalgam after 7T and 1.5T MRI in teeth that had been extracted from patients for clinical indications. While 7T MRI was approved by the FDA in 2017, it has extremely limited availability. The lower-strength 1.5T MRI is widely available and commonly used for patient exams.

The researchers opened two-sided cavities in each tooth and applied amalgam fillings. After nine days, two groups of 20 randomly selected teeth were placed in a solution of artificial saliva immediately followed by 20 minutes of exposure to 1.5T or 7T MRI. A control group of teeth was placed in artificial saliva only.

When the researchers analyzed the artificial saliva, the mercury content in the 7T, 1.5T and control group was 0.67 ± 0.18, 0.17 ± 0.06 and 0.14 ± 0.15 parts per million (ppm), respectively.  At 0.67 ppm, the mercury content in the 7T group was approximately four times the levels found in the 1.5T group and the control group.

“In our study, we found very high values of mercury after ultra-high-field MRI,” Yilmaz said. “This is possibly caused by phase change in amalgam material or by formation of microcircuits, which leads to electrochemical corrosion, induced by the magnetic field.”

An important point of discrimination concerning safety and hazard to human health is the amount of mercury that is absorbed by the vital tissues.

“It is not clear how much of this released mercury is absorbed by the body,” Yilmaz said.

Further studies may be warranted, Yilmaz added, to evaluate the relationship between high-field MRI and release of mercury from dental amalgam. The researchers have three ongoing projects focused on phase and temperature changes of dental amalgam across different magnetic fields.

As no evidence of harmful effects was found in the 1.5T group, patients with amalgam fillings should not be unduly concerned about having an MRI exam.

For more information: www.pubs.rsna.org/journal/radiology

Reference

Yilmaz S., Adisen M.Z. "Ex Vivo Mercury Release from Dental Amalgam after 7.0-T and 1.5-T MRI," Radiology. June 26, 2018. https://doi.org/10.1148/radiol.2018172597

Related Content

Smoldering Spots in the Brain May Signal Severe MS

NIH researchers found that dark rimmed spots representing ongoing, “smoldering” inflammation, may be a hallmark of more disabling forms of multiple sclerosis. Image courtesy of Reich lab, NIH/NINDS.

News | Neuro Imaging | August 22, 2019
Aided by a high-powered brain scanner and a 3-D printer, National Institutes of Health (NIH) researchers peered inside...
Vaping Impairs Vascular Function

Image courtesy of the American Heart Association

News | Magnetic Resonance Imaging (MRI) | August 21, 2019
Inhaling a vaporized liquid solution through an e-cigarette, otherwise known as vaping, immediately impacts vascular...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
New MRI Technique Captures Brain Changes in Near-real Time

Differences in stiffness between stimulus states. Image courtesy of Patz et al.

News | Neuro Imaging | August 19, 2019
An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an...
ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
First Patient Enrolled in World's Largest Brain Cancer Clinical Trial
News | Radiation Therapy | August 15, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive...